4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-23-027581
Chief Operating Officer gave up 2,624 shares (to pay taxes)
- Chief Operating Officer acquired 8,953 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2023-09-30 | Option exercise | +8,953 | 48,540 | D | ||
| Cittadine Andrew Chief Operating Officer | 2023-09-30 | Shares withheld for taxes | −2,624 | $0.62 | $1,627 | 45,916 | D |
| Derivatives | |||||||
| Cittadine Andrew Chief Operating Officer | 2023-09-30 | Option exercise · Restricted Stock Units | −8,953 | 100,127 | D | ||
Loading xslF345X05/rdgdoc.xml…